Fong Clow
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, Gastrointestinal Tumor Research and Treatment, Immunodeficiency and Autoimmune Disorders
Most-Cited Works
- → Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia(2013)2,236 cited
- → Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma(2013)1,668 cited
- → Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia(2014)1,603 cited
- → Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia(2015)1,539 cited
- → Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma(2015)1,102 cited
- → Ibrutinib in Previously Treated Waldenström’s Macroglobulinemia(2015)917 cited
- → Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial(2018)540 cited
- → Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial(2013)465 cited
- → Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study(2016)335 cited
- → Double-Blinded Randomized Study of High-Dose Calcitriol Plus Docetaxel Compared With Placebo Plus Docetaxel in Androgen-Independent Prostate Cancer: A Report From the ASCENT Investigators(2007)309 cited